TY - JOUR
T1 - Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form
AU - Parker, Matthew W.
AU - Linkugel, Andrew D.
AU - Goel, Hira Lal
AU - Wu, Tingting
AU - Mercurio, Arthur M.
AU - Vander Kooi, Craig W.
N1 - Publisher Copyright:
© 2015 Elsevier Ltd All rights reserved.
PY - 2015/4/7
Y1 - 2015/4/7
N2 - Vascular endothelial growth factor C (VEGF-C) is a potent lymphangiogenic cytokine that signals via the coordinated action of two cell surface receptors, Neuropilin-2 (Nrp2) and VEGFR-3. Diseases associated with both loss and gain of VEGF-C function, lymphedema and cancer, respectively, motivate studies of VEGF-C/Nrp2 binding and inhibition. Here, we demonstrate that VEGF-C binding to Nrp2 is regulated by C-terminal proteolytic maturation. The structure of the VEGF-C C terminus in complex with the ligand binding domains of Nrp2 demonstrates that a cryptic Nrp2 binding motif is released upon proteolysis, allowing specific engagement with the b1 domain of Nrp2. Based on the identified structural requirements for Nrp2 binding to VEGF-C, we hypothesized that the endogenous secreted splice form of Nrp2, s9Nrp2, may function as a selective inhibitor of VEGF-C. We find that s9Nrp2 forms a stable dimer that potently inhibits VEGF-C/Nrp2 binding and cellular signaling. These data provide critical insight into VEGF-C/Nrp2 binding and inhibition.
AB - Vascular endothelial growth factor C (VEGF-C) is a potent lymphangiogenic cytokine that signals via the coordinated action of two cell surface receptors, Neuropilin-2 (Nrp2) and VEGFR-3. Diseases associated with both loss and gain of VEGF-C function, lymphedema and cancer, respectively, motivate studies of VEGF-C/Nrp2 binding and inhibition. Here, we demonstrate that VEGF-C binding to Nrp2 is regulated by C-terminal proteolytic maturation. The structure of the VEGF-C C terminus in complex with the ligand binding domains of Nrp2 demonstrates that a cryptic Nrp2 binding motif is released upon proteolysis, allowing specific engagement with the b1 domain of Nrp2. Based on the identified structural requirements for Nrp2 binding to VEGF-C, we hypothesized that the endogenous secreted splice form of Nrp2, s9Nrp2, may function as a selective inhibitor of VEGF-C. We find that s9Nrp2 forms a stable dimer that potently inhibits VEGF-C/Nrp2 binding and cellular signaling. These data provide critical insight into VEGF-C/Nrp2 binding and inhibition.
UR - http://www.scopus.com/inward/record.url?scp=84926466448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926466448&partnerID=8YFLogxK
U2 - 10.1016/j.str.2015.01.018
DO - 10.1016/j.str.2015.01.018
M3 - Article
C2 - 25752543
AN - SCOPUS:84926466448
SN - 0969-2126
VL - 23
SP - 677
EP - 687
JO - Structure with Folding & design
JF - Structure with Folding & design
IS - 4
ER -